相关实验视频
Updated: May 29, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.3K
针对瘤细胞特异性幸存者基因沉默和抗瘤治疗的NQO1-可激活的循环反感性寡核酸
Xiaoran Zhao1, Jianfei Xu1, Xingxing Liang1
1State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center and School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Rd, Beijing 100191, China.
Journal of medicinal chemistry
|February 8, 2025
概括
在瘤细胞中,一种新型的循环反感性寡核酸 (cASO) 被NAD(P) H:酸氧降解酶-1 (NQO1) 激活. 这种NQO1响应系统实现了瘤特异性基因沉默,并显示出显著的抗瘤效应.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 在瘤细胞中,NAD(P) H:氨酸氧降解酶-1 (NQO1) 的表达很高.
- 在瘤中,NQO1可以被用作向药物释放的触发器.
- 反意义寡核酸 (ASO) 提供了基因沉默的潜力,但需要特定的传递策略.
研究的目的:
- 设计和评估一个NQO1-可激活的循环反感性寡核酸 (cASO) 用于瘤特异性基因沉默.
- 为了研究NQO1-介导激活和随后的基因沉默的机制.
- 在肺瘤模型中评估cASO的体外和体内疗效.
主要方法:
- 一个cASO的设计,包括一个NQO1-响应性 propionate (Q3PA) 和一个自燃链接器.
- 从头到尾的ASO循环,以防止过早的mRNA结合.
- 在体外研究评估瘤细胞特异性活性.
- 使用A549-Luc正型肺瘤模型进行体内研究,以评估抗瘤效应.
主要成果:
- 在被NQO1.1激活之前,cASO的圆形结构防止了基因沉默.
- NQO1触发了cASO转化为其线性,活性形式,导致基因沉默.
- 在体外观察到显著的瘤细胞特异性活性.
- 在体内证明了大量的抗瘤作用,与生存表达抑制有关.
结论:
- 可激活NQO1的cASO是一种可行的策略,用于瘤特异性基因沉默.
- 开发的cASO系统在癌症治疗方面显示出有前途的治疗潜力.
- 这种方法为增强的ASO疗法提供了一个新的前药物策略.
相关概念视频
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K

